Epicore Biosystems Raises Additional $6M; Expands Series B to $32M
Summary
The company intends to use the funds to expand its operations and accelerate its growth through new initiatives, including: • expand its Connected Hydration solution into industrial markets in Australia, the Middle East and Asia; • Validate new biomarkers for applications in kidney health and stress management. Led by CEO Dr. Roozbeh Ghaffari, Epicore Biosystems is a digital health company spun out of Northwestern University’s Querrey Simpson Institute for Bioelectronics and the John Rogers Laboratory. It has developed sweat-sensing wearables that provide real-time personalized health insights. Their clinically validated biowearable solutions and cloud analytics are deployed globally and licensed by Fortune 1000 companies, the Department of Defense, and the National Institute of Health. This latest investment followed Epicore’s initial $26M Series B raise led by the Steele Foundation for Hope, bringing its total Series B raise to $32M.